Myelin Pathology in Progressive Supranuclear Palsy

Myelin Pathology in Progressive Supranuclear Palsy

Overview

Myelin Pathology in Progressive Supranuclear Palsy

Overview

Myelin Pathology in Progressive Supranuclear Palsy represents a critical yet underappreciated component of PSP neuropathology. While PSP is classically characterized by tau-loaded neurons and glia, substantial white matter degeneration contributes to clinical manifestation, particularly gait impairment, axial rigidity, and pseudobulbar symptoms. This page synthesizes current understanding of myelin breakdown in PSP, its relationship to oligodendroglial tau pathology, comparison with other 4R tauopathies, and therapeutic implications.

Molecular Mechanisms of Myelin Breakdown in PSP

Primary Tau-Mediated Myelin Injury

In PSP, 4R tau pathology directly targets oligodendrocytes, the cells responsible for producing and maintaining the myelin sheath. Unlike Alzheimer's disease where myelin breakdown is largely secondary to neuronal loss, PSP demonstrates primary oligodendroglial involvement that precedes significant axonal degeneration in many cases[@dickson2020]. The mechanisms include:

Secondary Mechanisms

Beyond direct tau-mediated injury, secondary mechanisms amplify myelin loss:

Iron-Mediated Oxidative Damage: Elevated iron accumulation in PSP globus pallidus and Subthalamic nucleus extends to white matter tracts. Iron catalyzes hydroxyl radical formation through Fenton chemistry, causing lipid peroxidation of myelin membranes—rich in cholesterol and sphingolipids[@dexter1991].

Neuroinflammation-Driven Demyelination: Activated microglia in PSP white matter produce pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) that inhibit oligodendrocyte precursor differentiation and promote myelin breakdown. TSPO-PET studies demonstrate widespread microglial activation in PSP white matter beyond classical subcortical nuclei[@g2016].

Axonal Degeneration Feedback Loop: Tau-mediated axonal transport impairment in PSP leads to reduced neurotrophic support to oligodendrocytes. Axonal degeneration then triggers secondary myelin breakdown, creating a feed-forward destructive cascade[@bhattacharya2019].

Regional Pattern of White Matter Involvement

Most Affected Regions

Corticospinal Tract: Demyelination of corticospinal fibers contributes to spasticity and hyperreflexia in PSP. The degeneration is most prominent in the precentral gyrus white matter and internal capsule[@tsuboi2005].

Corpus Callosum: Interhemispheric connectivity disruption via callosal demyelination underlies the frontal lobe syndrome and axial rigidity in PSP. Advanced PSP cases show 40-60% reduction in corpus callosal thickness[@quattrone2008].

Brainstem White Matter: The pontine crossing fibers and tegmental tracts show prominent myelin loss, contributing to gait impairment, postural instability, and ocular motor deficits. This correlates with the characteristic "hummingbird" sign on mid-sagittal MRI[@matsusue2007].

Internal Capsule and Basal Ganglia White Matter: White matter in the region of the globus pallidus and internal capsule shows early involvement, reflecting the selective vulnerability of basal ganglia circuits[@scherder2014].

Regional Vulnerability Gradient

The pattern of white matter involvement in PSP follows a characteristic gradient:

This gradient mirrors the distribution of 4R tau pathology in oligodendrocytes and explains the prominent subcortical clinical features of PSP[@kovacs2017].

Comparison with Other Tauopathies

PSP vs. Corticobasal Syndrome (CBS)

Both PSP and CBS are 4R tauopathies, but myelin pathology differs:

| Feature | PSP | CBS |
|---------|-----|-----|
| Oligodendroglial tau | Prominent, early | Variable, often later |
| White matter burden | Symmetric, subcortical | Asymmetric, cortical/subcortical |
| Distribution pattern | Brainstem-predominant | Cortical-predominant |
| Myelin loss severity | Moderate-severe | Variable |

CBS shows more asymmetric white matter involvement reflecting the hemiparetic clinical presentation, while PSP demonstrates symmetric brainstem-predominant demyelination[@alexander2014].

PSP vs. Alzheimer's Disease

The myelin pathology profiles differ substantially:

• AD: Myelin breakdown is secondary to synaptic and neuronal loss, with tau pathology primarily neuronal
• PSP: Primary oligodendroglial tau pathology causes early, independent myelin degeneration
• AD shows temporoparietal white matter predomination; PSP shows subcortical/brainstem predomination[@barker2019]

PSP vs. Multiple System Atrophy (MSA)

MSA and PSP both involve oligodendrocytes, but with different pathological proteins:

| Feature | PSP | MSA |
|---------|-----|-----|
| Oligodendroglial inclusion | Tau (4R) | Alpha-synuclein |
| Myelin pathology timing | Primary | Primary |
| White matter pattern | Subcortical/brainstem | Cerebellar/brainstem |
| Glial cytoplasmic inclusions | Absent | Present |

Despite both being "oligodendrogliopathies," the myelin breakdown patterns differ due to distinct protein aggregates and regional vulnerabilities[@jellinger2018].

MRI and Imaging Biomarkers

Conventional MRI Findings

• T2/FLAIR hyperintensities: Subcortical white matter hyperintensities in PSP, particularly in the frontal lobes and brainstem
• Atrophy patterns: Callosal atrophy (midbody thinning), pontine atrophy, and selective midbrain atrophy
• "Hummingbird" sign: Visualized on mid-sagittal T1 as atrophy of the midbrain relative to pons[@schwarz2016]

Advanced Imaging Markers

Diffusion Tensor Imaging (DTI) reveals:

• Reduced fractional anisotropy (FA) in corpus callosum, internal capsule, and corticospinal tracts
• Elevated mean diffusivity (MD) in PSP white matter correlates with clinical severity[@zhang2019]

• Reduced N-acetylaspartate (NAA) in white matter indicates axonal loss
• Elevated choline reflects demyelination[@menke2009]

• Reduced [11C]PIB binding in white matter suggests minimal amyloid co-pathology in classic PSP
• TSPO-PET shows microglial activation correlating with white matter inflammation[@mal2018]

Clinical Correlations

Gait and Balance

White matter degeneration in the brainstem and basal ganglia contributes significantly to the postural instability and falls that characterize PSP. Damage to reticulospinal tracts impairs postural reflexes, while corticospinal tract involvement contributes to axial rigidity[@wenning2021].

Oculomotor Deficits

Demyelination of the pretectal region and ocular motor nuclei contributes to vertical supranuclear gaze palsy. The characteristic downgaze deficit correlates with white matter changes in the pretectal area[@leigh2017].

Cognitive Impairment

Frontal white matter disconnection—via corpus callosal demyelination—underlies the frontal lobe syndrome in PSP. Executive dysfunction correlates with DTI measures of frontal white matter integrity[@khanna2019].

Pseudobulbar Affect

White matter involvement in the pontine tegmentum and corticobulbar tracts contributes to dysarthria and pseudobulbar affect, common in PSP[@kertel2011].

Therapeutic Implications

Current Approaches

Tau-Targeted Therapies:

• ASO therapies (BIIB080, IONIS-MAPTRx) may reduce oligodendroglial tau production
• Anti-tau antibodies (gosuranemab, tilavonemab) failed in PSP—potentially due to insufficient white matter penetration[@tisdall2022]

• Clemastine and benztropine promote remyelination in preclinical models
• No clinical trials specifically targeting remyelination in PSP[@meiral2020]

Emerging Strategies

Lipid-Based Therapeutics: Myelin is rich in cholesterol and galactosylceramides. Approaches to stabilize myelin lipids show promise in preclinical models[@saher2011].

Oligodendrocyte Precursor Cell (OPC) Stimulation: PDGFRα agonists promote OPC differentiation into mature oligodendrocytes. This approach could potentially reverse myelin loss in PSP[@sim2019].

Iron Chelation: Deferoxamine and deferasirox may reduce iron-mediated myelin oxidative damage, though clinical trials in PSP have been limited[@weinberger2006].

Research Gaps and Future Directions

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving Myelin Pathology in Progressive Supranuclear Palsy discovered through SciDEX knowledge graph analysis: